[Skip to Navigation]
February 1997

Acquired Immunodeficiency Syndrome and the Eye-Reply

Author Affiliations

Baltimore, Md

Arch Ophthalmol. 1997;115(2):293. doi:10.1001/archopht.1997.01100150294034

In reply  Dr Brein asks 2 important questions. The first is the frequency with which individuals with human immunodeficiency virus infection should receive ophthalmologic examinations. For patients with known cytomegalovirus (CMV) retinitis, many experienced clinicians recommend monthly follow-up visits. Approximately 1 month is required after the initiation of therapy for the lesions to appear quiet,1 and approximately 1 month is required for the lesion borders to move a clinically recognizable distance. Hence, monthly follow-up visits seem to be reasonable. Some experts will have an additional visit 2 weeks after the initiation of the therapy. The purposes of this visit are to confirm the diagnosis and to confirm that the lesions are not worsening after initial therapy. For patients treated with the ganciclovir intraocular device, typical postoperative follow-up visits are used initially (ie, at 1 day, 1 week, and then 1 month after surgery). Regardless of the form of therapy,

Add or change institution